FDA-Drug2014-07-23Class III
Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67
Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: out of specification impurity test results.
Sold states
Nationwide
Affected count
5265 blister packs
Manufactured in
1090 Horsham Rd, N/A, North Wales, PA, United States
Products
Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1439-2014Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief